From: Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice
Group | n | HR(Times/min) | ASBP(mmHg) | LVSP(mmHg) | LVEDP(mmHg) | dp/dtmax(mmHg/s) | -dp/dtmax(mmHg/s) |
---|---|---|---|---|---|---|---|
Sham | 9 | 413.75 ± 6.03 | 90.36 ± 2.66 | 84.58 ± 2.91 | −1.97 ± 1.17 | 4665.30 ± 107.62 | −3792.47 ± 114.30 |
Model | 6 | 456.60 ± 3.82** | 90.79 ± 6.13 | 89.67 ± 5.39 | −1.62 ± 0.87 | 4816.32 ± 158.86 | −4162.92 ± 137.04 |
XJEK | 8 | 376.86 ± 16.22## | 84.98 ± 8.87 | 85.35 ± 3.75 | −0.47 ± 0.83 | 3786.10 ± 213.42## | −2977.76 ± 153.14## |
Fosinopril | 7 | 427.50 ± 11.08# | 78.66 ± 8.12 | 83.55 ± 7.32 | −1.13 ± 3.34 | 3551.12 ± 296.28## | −2818.68 ± 281.20## |